Brief: Citius Pharma's Unit To Merge With Tenx Keane Acquisition To Form Publicly Listed Citius Oncology

Citius Oncology

24/10/2023 13:40

Oct 24 (Reuters) - Citius Pharmaceuticals Inc  CTXR.O :
    * CITIUS PHARMACEUTICALS EXECUTES DEFINITIVE AGREEMENT TO
MERGE
WHOLLY OWNED SUBSIDIARY WITH TENX KEANE ACQUISITION TO FORM
PUBLICLY LISTED CITIUS ONCOLOGY, INC.
    * CITIUS PHARMACEUTICALS INC - PROPOSED DEAL FOR CITIUS
PHARMA
WOULD RECEIVE 67.5 MILLION SHARES IN CITIUS ONCOLOGY AT $10 PER
SHARE
    * CITIUS PHARMACEUTICALS INC: TRANSACTION ANTICIPATED TO
CLOSE IN
FIRST HALF OF 2024

Source text for Eikon:  ID:nGNX5G2vSv 
Further company coverage:  CTXR.O 

 ((Reuters.Briefs@thomsonreuters.com))